Cohort I | Cohort II | |||||
---|---|---|---|---|---|---|
Low HMG-CoAR (%) (n = 62) | High HMG-CoAR (%) (n = 93) | P value (χ2test) | HMG-CoAR-negative (%) (n = 222) | HMG-CoAR-positive (%) (n = 200) | P value (χ2test) | |
Age (years) | ||||||
<median | 34 (55) | 42 (45) | 0.238 | 36 (16) | 36 (18) | 0.612 |
>median | 28 (45) | 51 (55) | 186 (84) | 164 (82) | ||
Tumor size | ||||||
0 to 20 mm | 21 (35) | 57 (63) | 0.003 | 75 (34) | 79 (40) | 0.196 |
>21 mm | 39 (65) | 33 (37) | 147 (66) | 120 (60) | ||
Missing | 5 | |||||
Histological subtype | ||||||
Ductal | 49 (79) | 75 (81) | 0.250 | 181 (91) | 171 (93) | 0.581 |
Others | 13 (21) | 18 (19) | 17 (9) | 13 (7) | ||
Unknown | 40 | |||||
Nodal status | ||||||
N0 | 21 (35) | 57 (63) | 0.003 | 70 (32) | 42 (21) | 0.009 |
N1+ | 39 (65) | 33 (37) | 152 (68) | 158 (79) | ||
Unknown | 5 | |||||
Nottingham Histological Grade | ||||||
I | 9 (15) | 12 (13) | 0.535 | 15 (7) | 28 (15) | 0.009 |
II | 38 (60) | 56 (60) | 85 (40) | 86 (45) | ||
III | 10 (14) | 23 (27) | 115 (53) | 79 (40) | ||
Unknown | 7 | 14 | ||||
ER status | ||||||
Negative | 80 (38) | 54 (28) | 0.026 | |||
Positive | 130 (62) | 141 (72) | ||||
Unknown | 17 | |||||
PR status | ||||||
Negative | 78 (38) | 56 (30) | 0.098 | |||
Positive | 130 (62) | 133 (70) | ||||
Unknown | 25 | |||||
Ki-67 | ||||||
<10% | 138 (73) | 128 (71) | 0.658 | |||
>10% | 52 (27) | 53 (29) | ||||
Unknown | 51 | |||||
Her2 immunohistochemistry | ||||||
0 to 2+ | 173 (90) | 137 (80) | 0.008 | |||
3+ | 20 (10) | 35 (20) | ||||
Unknown | 57 |